Stay updated on Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial

Sign up to get notified when there's something new on the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The record presents details of the completed Phase 2 study of bemcentinib plus pembrolizumab for advanced lung cancer, including study outcomes, eligibility, participating locations, and supporting documents.
    Difference
    69%
    Check dated 2026-11-09T13:25:31.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T13:22:44.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A site-wide banner announces an NIH terminology transition, saying “Super Intelligence” is being used in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-26T13:45:09.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer's site revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-19T13:48:00.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The page remains a 403 Forbidden error page, while the footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T14:34:40.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error with a minimal header and a Home link, replacing the previous detailed study content and sections.
    Difference
    21%
    Check dated 2026-09-21T20:40:06.000Z thumbnail image

Stay in the know with updates to Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.